HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Myeloma News

The HealthTree News for Myeloma is a place to learn all about Myeloma in easy-to-understand language. The site features news articles, patient stories, Myeloma basics articles, and clinical trial updates with new content every week.

ASH 2022: A New Option for High-Risk Smoldering Myeloma Patients

Jan. 24, 2023

ASH 2022: A New Option for High-Risk Smoldering Myeloma Patients

ASH 2022:  Talquetamab for Relapsed/Refractory Myeloma Showing Durable Responses

Jan. 24, 2023

ASH 2022: Talquetamab for Relapsed/Refractory Myeloma Showing Durable Responses

ASH 2022: Improved Quality of Life on Quad Therapy

Jan. 22, 2023

ASH 2022: Improved Quality of Life on Quad Therapy

Starting Your Myeloma Journal

Jan. 22, 2023

Starting Your Myeloma Journal

ASH 2022:  Elranatamab Bispecific Shows Promise in Multiple Myeloma

Jan. 19, 2023

ASH 2022: Elranatamab Bispecific Shows Promise in Multiple Myeloma

ASH 2022: New Bispecific Combinations Studied in Relapsed/Refractory Myeloma

Jan. 19, 2023

ASH 2022: New Bispecific Combinations Studied in Relapsed/Refractory Myeloma

Save the Date(s): Austin, Indianapolis, Raleigh-Durham Myeloma Round Tables, Spring 2023

Jan. 18, 2023

Save the Date(s): Austin, Indianapolis, Raleigh-Durham Myeloma Round Tables, Spring 2023

ASH 2022:  Faster, More Effective CAR T in Development by BMS for Multiple Myeloma

Jan. 17, 2023

ASH 2022: Faster, More Effective CAR T in Development by BMS for Multiple Myeloma

What is Plasma Cell Enrichment and How Does it Help Obtain Better Test Results in Multiple Myeloma?

Jan. 17, 2023

What is Plasma Cell Enrichment and How Does it Help Obtain Better Test Results in Multiple Myeloma?

ASH 2022:  The MRD2STOP Study Could Change the Face of Maintenance

Jan. 16, 2023

ASH 2022: The MRD2STOP Study Could Change the Face of Maintenance

ASH 2022: Cancer Causes Distress. No Duh!

Jan. 12, 2023

ASH 2022: Cancer Causes Distress. No Duh!

ASH 2022: Factors Influencing Black Patient Participation in Clinical Trials

Jan. 09, 2023

ASH 2022: Factors Influencing Black Patient Participation in Clinical Trials

Recent Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Amgen Oncology
Abbvie
Genentech
GSK
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube